Distinguishing between cancer driver and passenger gene alteration candidates via cross-species comparison: a pilot study

BackgroundWe are developing a cross-species comparison strategy to distinguish between cancer driver- and passenger gene alteration candidates, by utilizing the difference in genomic location of orthologous genes between the human and other mammals. As an initial test of this strategy, we conducted a pilot study with human colorectal cancer (CRC) and its mouse model C57BL/6J ApcMin/+, focusing on human 5q22.2 and 18q21.1-q21.2.MethodsWe first performed bioinformatics analysis on the evolution of 5q22.2 and 18q21.1-q21.2 regions. Then, we performed exon-targeted sequencing, real time quantitative polymerase chain reaction (qPCR), and real time quantitative reverse transcriptase PCR (qRT-PCR) analyses on a number of genes of both regions with both human and mouse colon tumors.ResultsThese two regions (5q22.2 and 18q21.1-q21.2) are frequently deleted in human CRCs and encode genuine colorectal tumor suppressors APC and SMAD4. They also encode genes such as MCC (mutated in colorectal cancer) with their role in CRC etiology unknown. We have discovered that both regions are evolutionarily unstable, resulting in genes that are clustered in each human region being found scattered at several distinct loci in the genome of many other species. For instance, APC and MCC are within 200 kb apart in human 5q22.2 but are 10 Mb apart in the mouse genome. Importantly, our analyses revealed that, while known CRC driver genes APC and SMAD4 were disrupted in both human colorectal tumors and tumors from ApcMin/+ mice, the questionable MCC gene was disrupted in human tumors but appeared to be intact in mouse tumors.ConclusionsThese results indicate that MCC may not actually play any causative role in early colorectal tumorigenesis. We also hypothesize that its disruption in human CRCs is likely a mere result of its close proximity to APC in the human genome. Expanding this pilot study to the entire genome may identify more questionable genes like MCC, facilitating the discovery of new CRC driver gene candidates.

[1]  Christopher A. Miller,et al.  A sequence-level map of chromosomal breakpoints in the MCF-7 breast cancer cell line yields insights into the evolution of a cancer genome. , 2009, Genome research.

[2]  R. Weinberg,et al.  Phenotype of mice lacking functional Deleted in colorectal cancer (Dec) gene , 1997, Nature.

[3]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[4]  J. Massagué,et al.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.

[5]  K. Kinzler,et al.  Frequency of Smad gene mutations in human cancers. , 1997, Cancer research.

[6]  Yidong Chen,et al.  Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genome. , 2008, Cancer research.

[7]  A. Delcher,et al.  Human, mouse, and rat genome large-scale rearrangements: stability versus speciation. , 2004, Genome research.

[8]  M. Arends,et al.  DNA mismatch repair and colorectal cancer , 1998, The Journal of pathology.

[9]  Li Li,et al.  High‐resolution genomic and expression analyses of copy number alterations in breast tumors , 2008, Genes, chromosomes & cancer.

[10]  M. Lindstrom,et al.  ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Scott E. Kern,et al.  Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers , 1996, Nature Genetics.

[12]  T. Yeatman,et al.  Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer , 2007, Genome Biology.

[13]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[14]  Kathleen R. Cho,et al.  Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. , 2007, Cancer research.

[15]  K. Dewar,et al.  Comparative genomic analysis of the clade B serpin cluster at human chromosome 18q21: amplification within the mouse squamous cell carcinoma antigen gene locus. , 2004, Genomics.

[16]  Richard B Halberg,et al.  Tumor regionality in the mouse intestine reflects the mechanism of loss of Apc function. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  A. Clarke.  Studying the consequences of immediate loss of gene function in the intestine: APC. , 2005, Biochemical Society transactions.

[18]  J. Massagué,et al.  TGFbeta signaling in growth control, cancer, and heritable disorders. , 2000, Cell.

[19]  P. Pevzner,et al.  Human and mouse genomic sequences reveal extensive breakpoint reuse in mammalian evolution , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[20]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[21]  K. Kinzler,et al.  Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. , 1991, Science.

[22]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[23]  W F Bodmer,et al.  The ABC of APC. , 2001, Human molecular genetics.

[24]  N. Petrelli,et al.  The onset and extent of genomic instability in sporadic colorectal tumor progression. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Shaying Zhao,et al.  DA and Xiao-two giant and composite LTR-retrotransposon-like elements identified in the human genome. , 2008, Genomics.

[26]  R. Gibbs,et al.  Basic Principles and Technologies for Deciphering the Genetic Map of Cancer , 2009, World Journal of Surgery.

[27]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[28]  C Caldas,et al.  High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation , 2006, Oncogene.

[29]  M. Batzer,et al.  Mammalian retroelements. , 2002, Genome research.

[30]  Hiroyuki Miyoshi,et al.  Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes , 1998, Cell.

[31]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[32]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[33]  B. Aronow,et al.  Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors. , 2005, Cancer research.

[34]  E. Korn,et al.  Stage‐specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis , 2007, Genes, chromosomes & cancer.

[35]  T. Yeatman,et al.  Copy number abnormalities in sporadic canine colorectal cancers. , 2010, Genome research.

[36]  D. Albertson,et al.  Long-lived Min mice develop advanced intestinal cancers through a genetically conservative pathway. , 2009, Cancer research.

[37]  R. Simon,et al.  Aneuploidy-dependent massive deregulation of the cellular transcriptome and apparent divergence of the Wnt/beta-catenin signaling pathway in human rectal carcinomas. , 2006, Cancer research.

[38]  E. Lander,et al.  Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.

[39]  R. Green,et al.  APC mutations lead to cytokinetic failures in vitro and tetraploid genotypes in Min mice , 2007, The Journal of cell biology.

[40]  A. Lowy,et al.  Adenomatous polyposis coli/beta-catenin interaction and downstream targets: altered gene expression in gastrointestinal tumors. , 2003, Clinical colorectal cancer.

[41]  H. Clevers,et al.  Linking Colorectal Cancer to Wnt Signaling , 2000, Cell.

[42]  Juan José Lozano,et al.  Genome-wide differences between microsatellite stable and unstable colorectal tumors. , 2006, Carcinogenesis.

[43]  V. Noskov,et al.  Evolution of the tumor suppressor BRCA1 locus in primates: implications for cancer predisposition. , 2004, Human molecular genetics.

[44]  A. Moser,et al.  ApcMin: a mouse model for intestinal and mammary tumorigenesis. , 1995, European journal of cancer.

[45]  G. Parmigiani,et al.  The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.

[46]  Scott E. Kern,et al.  DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.

[47]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[48]  G. Boivin,et al.  Mouse Models of Intestinal Cancer. , 2004, Comparative medicine.

[49]  C. Midgley,et al.  A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M Oshima,et al.  Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. , 1999, Cancer research.

[51]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[52]  Martin A. Nowak,et al.  The significance of unstable chromosomes in colorectal cancer , 2003, Nature Reviews Cancer.

[53]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.